↓ Skip to main content

MDPI

SupT1 Cell Infusion as a Possible Cell-Based Therapy for HIV: Results from a Pilot Study in Hu-PBMC BRGS Mice

Overview of attention for article published in Vaccines, April 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#25 of 4,614)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
70 news outlets
twitter
174 X users
wikipedia
6 Wikipedia pages

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
11 Mendeley
Title
SupT1 Cell Infusion as a Possible Cell-Based Therapy for HIV: Results from a Pilot Study in Hu-PBMC BRGS Mice
Published in
Vaccines, April 2016
DOI 10.3390/vaccines4020013
Pubmed ID
Authors

Jonathan Fior

X Demographics

X Demographics

The data shown below were collected from the profiles of 174 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 18%
Unspecified 1 9%
Other 1 9%
Student > Doctoral Student 1 9%
Lecturer 1 9%
Other 2 18%
Unknown 3 27%
Readers by discipline Count As %
Immunology and Microbiology 2 18%
Veterinary Science and Veterinary Medicine 1 9%
Unspecified 1 9%
Business, Management and Accounting 1 9%
Biochemistry, Genetics and Molecular Biology 1 9%
Other 2 18%
Unknown 3 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 694. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 July 2024.
All research outputs
#31,845
of 26,375,927 outputs
Outputs from Vaccines
#25
of 4,614 outputs
Outputs of similar age
#538
of 314,488 outputs
Outputs of similar age from Vaccines
#1
of 10 outputs
Altmetric has tracked 26,375,927 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,614 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 314,488 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them